Barry S. Ticho

Co-Founder at Verve Therapeutics, Inc.

Barry S. Ticho

Barry S. Ticho

Co-Founder at Verve Therapeutics, Inc.

Overview
Career Highlights

Verve Therapeutics, Inc.

RelSci Relationships

4532

Number of Boards

3

Birthday

1960

Age

60

Relationships
RelSci Relationships are individuals Barry S. Ticho likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Verve Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Verve Therapeutics, Inc.

Relationship likelihood: Strong

Chief Business Officer at The Broad Institute, Inc.

Relationship likelihood: Strong

Venture Partner at GV Management Co. LLC

Relationship likelihood: Strong

General Partner at GV Management Co. LLC

Relationship likelihood: Strong

Co-Founder at Verve Therapeutics, Inc.

Relationship likelihood: Strong

Venture Partner at ARCH Venture Partners

Relationship likelihood: Strong

Managing Director at Bng0 LLC

Relationship likelihood: Strong

Chief Financial Officer & Principal Accounting Officer at Stoke Therapeutics, Inc.

Relationship likelihood: Strong

Director-Northeast Chapter at Association of Corporate Counsel

Relationship likelihood: Strong

Paths to Barry S. Ticho
Potential Connections via
Relationship Science
You
Barry S. Ticho
Co-Founder at Verve Therapeutics, Inc.
Education
PhD

The University of Chicago's Office of Investments (COI) is responsible for managing the University's investment assets, which includes overseeing the endowment to ensure that it benefits both current and future generations of the University of Chicago. COI oversees the broad investment strategy and provides input to the development of the strategic and tactical investment policies of the University & UCMC endowments, pension plans and self-insurance trust assets. Their strategy combines qualitative and quantitative analysis, seeking to achieve superior investment performance on a risk-adjusted basis.COI's approach seeks to evaluate the investment strategy as an integrated part of the operating plans of the University rather than in isolation and focuses the the University's overall success, not investment returns. The endowment is well-diversified across a variety of asset classes, including global stocks and bonds, real estate, natural resources, private equity, absolute return strategies and protection (tail-hedging strategies). Asset class exposure is achieved primarily by selecting and engaging external managers. COI manages the global macro and the overlay portfolio to ensure that the portfolio's overall positioning is compliance with the endowment's investment guidelines.COI's strategies for investing in the public markets include: Absolute Return, Private Debt, Fixed Income and Credit. and Global Equities.COI's real assets team invests globally in real estate and natural resources using outside managers. The real estate portfolio invests globally in value-added and opportunistic strategies using both private partnerships and public vehicles. The natural resources portfolio invests globally in strategies that include, but are not limited to: oil and gas exploration & production; power generation; infrastructure; timber; mining and minerals; and agriculture.

Haverford is one of America's leading liberal arts colleges, a close-knit intellectual community that combines the Quaker values of dignity, tolerance and respect with a rigorous academic program.

MD

The Pritzker School of Medicine is the M.D. granting unit of the Biological Sciences Division of the University of Chicago. It is located on the University's main campus in the historic Hyde Park neighborhood of Chicago, and matriculated its first class in 1927.As one of the most selective medical schools in the United States, it is currently ranked 10th among research universities for medical education by the US News & World Report.

Career History
Clinical Pharmacology
Prior

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Vice President-Clinical Development
2000 - 2013

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Head-External Research & Development Innovation
2013 - 2016

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Boards & Committees
Director
2019 - Current

Verve Therapeutics, Inc. is a bio technology company, which focuses to protect the world from heart disease. It researches, develops and manufactures cardiology & genetic medicines. The company was founded by Sekar Kathiresan, Kiran Musunuru, Keith J. Joung, Issi Rozen, Sekar Kathiresan, and Burt A. Adelman and is headquartered in Cambridge, MA.

Member, Board of Directors
Tenure Unconfirmed

Provasculon, Inc. develops new treatments for chronic wounds and cardiovascular diseases. The company was founded by Thomas Lee Richard and Vincent M. Segers in 2008 and is headquartered in Boston, MA.

Member, Board of Museum Advisors
Prior

Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA.

Transactions
Details Hidden

Stoke Therapeutics, Inc. raised money in a private placement transaction

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Barry S. Ticho. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Barry S. Ticho's profile does not indicate a business or promotional relationship of any kind between RelSci and Barry S. Ticho.